Tryptophan prototrophy contributes to Francisella tularensis evasion of gamma interferon-mediated host defense

Infection and Immunity

Volumn 79, Issue 6, 2011, Pages 2356-2361

  Chu, Ping ^a   Rodriguez, Annette R ^a   Arulanandam, Bernard P ^a   Klose, Karl E ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; TRYPTOPHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUXOTROPHY; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BONE MARROW CELL; CELL SURVIVAL; CONTROLLED STUDY; FRANCISELLA TULARENSIS; FRANCISELLA TULARENSIS SUBSP NOVICIDA; HOST RESISTANCE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TULAREMIA;

ANIMALS; FRANCISELLA TULARENSIS; GENES, BACTERIAL; HOST-PATHOGEN INTERACTIONS; INTERFERON-GAMMA; MACROPHAGES; MICE; MICE, INBRED C57BL; TRYPTOPHAN; TULAREMIA;

EID: 79959463532     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01349-10     Document Type: Article

References (35)

1. Alkhuder, K., K. L. Meibom, I. Dubail, M. Dupuis, and A. Charbit. 2009. Glutathione provides a source of cysteine essential for intracellular multiplication of Francisella tularensis. PLoS Pathog. 5:e1000284.
2. Anthony, L. S., P. J. Morrissey, and F. E. Nano. 1992. Growth inhibition of Francisella tularensis live vaccine strain by IFN-gamma-activated macrophages is mediated by reactive nitrogen intermediates derived from L-arginine metabolism. J. Immunol. 148:1829-1834.
3. Barker, J. R., et al. 2009. The Francisella tularensis pathogenicity island encodes a secretion system that is required for phagosome escape and virulence. Mol. Microbiol. 74:1459-1470.
4. Beatty, W. L., T. A. Belanger, A. A. Desai, R. P. Morrison, and G. I. Byrne. 1994. Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence. Infect. Immun. 62:3705-3711.
5. Bosio, C. M., and K. L. Elkins. 2001. Susceptibility to secondary Francisella tularensis live vaccine strain infection in B-cell-deficient mice is associated with neutrophilia but not with defects in specific T-cell-mediated immunity. Infect. Immun. 69:194-203.
6. Chamberlain, R. E. 1965. Evaluation of live tularemia vaccine prepared in a chemically defined medium. Appl. Microbiol. 13:232-235.
7. Champion, M. D., et al. 2009. Comparative genomic characterization of Francisella tularensis strains belonging to low and high virulence subspecies. PLoS Pathog. 5:31000459.
8. Checroun, C., T. D. Wehrly, E. R. Fischer, S. F. Hayes, and J. Celli. 2006. Autophagy-mediated reentry of Francisella tularensis into the endocytic compartment after cytoplasmic replication. Proc. Natl. Acad. Sci. U. S. A. 103:14578-14583.
9. Edwards, J. A., D. Rockx-Brouwer, V. Nair, and J. Celli. 2010. Restricted cytosolic growth of Francisella tularensis subsp. tularensis by IFN-g activation of macrophages. Microbiol. 156:327-339.
10. Elkins, K. L., S. C. Cowley, and C. M. Bosio. 2003. Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain. Microbes Infect. 5:132-142.
11. Forestal, C. A., et al. 2007. Francisella tularensis has a significant extracellular phase in infected mice. J. Infect. Dis. 196:134-137.
12. Forslund, A. L., et al. 2006. Direct repeat-mediated deletion of a type IV pilin gene results in major virulence attenuation of Francisella tularensis. Mol. Microbiol. 59:1818-1830.
13. Fortier, A. H., T. Polsinelli, S. J. Green, and C. A. Nacy. 1992. Activation of macrophages for destruction of Francisella tularensis: identification of cytokines, effector cells, and effector molecules. Infect. Immun. 60:817-825.
14. Gallagher, L. A., et al. 2007. A comprehensive transposon mutant library of Francisella novicida, a bioweapon surrogate. Proc. Natl. Acad. Sci. U. S. A. 104:1009-1014.
15. Golovliov, I., V. Baranov, Z. Krocova, H. Kovarova, and A. Sjostedt. 2003. An attenuated strain of the facultative intracellular bacterium Francisella tularensis can escape the phagosome of monocytic cells. Infect. Immun. 71:5940-5950.
16. Hu, X., S. D. Chakravarty, and L. B. Ivashkiv. 2008. Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms. Immunol. Rev. 226:41-56.
17. Lai, X. H., I. Golovliov, and A. Sjostedt. 2004. Expression of IglC is necessary for intracellular growth and induction of apoptosis in murine macrophages by Francisella tularensis. Microb. Pathog. 37:225-230.
18. Larsson, P., et al. 2005. The complete genome sequence of Francisella tularensis, the causative agent of tularemia. Nat. Genet. 37:153-159.
19. Lauriano, C. M., J. R. Barker, F. E. Nano, B. P. Arulanandam, and K. E. Klose. 2003. Allelic exchange in Francisella tularensis using PCR products. FEMS Microbiol. Lett. 229:195-202.
20. Lauriano, C. M., et al. 2004. MglA regulates transcription of virulence factors necessary for Francisella tularensis intra-amoebae and intra-macrophage survival. Proc. Natl. Acad. Sci. U. S. A. 101:4246-4249.
21. Li, J., et al. 2007. Attenuation and protective efficacy of an O-antigendeficient mutant of Francisella tularensis LVS. Microbiol. 153:3141-3153.
22. Lindgren, H., et al. 2007. Resistance of Francisella tularensis strains against reactive nitrogen and oxygen species with special reference to the role of KatG. Infect. Immun. 75:1303-1309.
23. Lindgren, H., S. Stenmark, W. Chen, A. Tarnvik, and A. Sjostedt. 2004. Distinct roles of reactive nitrogen and oxygen species to control infection with the facultative intracellular bacterium Francisella tularensis. Infect. Immun. 72:7172-7182.
24. Liu, J., X. Zogaj, J. R. Barker, and K. E. Klose. 2007. Construction of targeted insertion mutations in Francisella tularensis subsp. novicida. Biotechniques 43:487-490.
25. Maier, T. M., R. D. Pechous, M. Casey, T. C. Zahrt, and D. W. Frank. 2006. In vivo himar1-based transposon mutagenesis of Francisella tularensis. Appl. Environ. Microbiol. 72:1878-1885.
26. Miles, E. W. 1991. Structural basis for catalysis by tryptophan synthase. Adv. Enzymol. Relat. Areas Mol. Biol. 64:93-172.
27. Nano, F. E., et al. 2004. A Francisella tularensis pathogenicity island required for intramacrophage growth. J. Bacteriol. 186:6430-6436.
28. Pechous, R. D., et al. 2008. A Francisella tularensis SchuS4 purine auxotroph is highly attenuated in mice but offers limited protection against homologous intranasal challenge. PLoS One 3:e2487.
29. Pechous, R. D., T. R. McCarthy, and T. C. Zahrt. 2009. Working toward the future: insights into Francisella tularensis pathogenesis and vaccine development. Microbiol. Mol. Biol. Rev. 73:684-711.
30. Peng, K., and D. M. Monack. 2010. Indoleamine 2,3-dioxygenase 1 is a lung-specific immune defense mechanism that inhibits Francisella tularensis tryptophan auxotrophs. Infect. Immun. 78:2723-2733.
31. Rodriguez, S. A., J.-J. Yu, G. Davis, B. P. Arulanandam, and K. E. Klose. 2008. Targeted inactivation of Francisella tularensis genes by group II introns. Appl. Environ. Microbiol. 74:2619-2626.
32. Sandstrom, G., S. Lofgren, and A. Tarnvik. 1988. A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes. Infect. Immun. 56:1194-1202.
33. Santiago, A. E., et al. 2009. Characterization of rationally attenuated Francisella tularensis vaccine strains that harbor deletions in the guaA and guaB genes. Vaccine 27:2426-2436.
34. Twine, S., et al. 2005. A mutant of Francisella tularensis strain Schu S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine. Infect. Immun. 73:8345-8352.
35. Yu, J.-J., et al. 2008. The presence of infectious extracellular Francisella tularensis subsp. novicida in murine plasma after pulmonary challenge. Eur. J. Clin. Microbiol. Infect. Dis. 27:323-325.